VBI will present at the LD Micro Conference on Wednesday, December 3rd at 9:00 AM PT. The event is being held in Los Angeles, CA at the Luxe Sunset Boulevard Hotel.

At the conference, Jeff Baxter, VBI’s President and CEO, will discuss current company developments and will meet with select investors for one-on-one meetings. For additional information, visit: http://ldmicro.com/companies/vbiv/

“Having only recently made our NASDAQ debut, we are pleased to share our progress with a broader community of investors,” commented Mr. Baxter. “We continue to make progress on multiple fronts, including on the development of our lead candidate, a prophylactic Cytomegalovirus (“CMV”) vaccine.”

Following the conference, VBI’s corporate presentation will be made available in the Investor Relations section of VBI’s website: http://ir.vbivaccines.com/presentations